Surveillance For New Lung Primaries
Terminated
- Conditions
- Lung Cancer
- Registration Number
- NCT00205413
- Lead Sponsor
- University of Wisconsin, Madison
- Brief Summary
This clinical research protocol proposes to perform low dose helical computed tomographic (CT) scanning in 250 high-risk patients (125/year for two years) in order to detect lung carcinomas when they are small and subject to effective curative therapies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
- Asymptomatic
Exclusion Criteria
- 20 pack year history
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of low-dose helical CT in early-stage lung cancer detection for NCT00205413?
How does anatomic co-registered CT/PET improve diagnostic accuracy for indeterminate 5-9 mm nodules compared to standard imaging techniques?
Which biomarkers are associated with high-risk patient selection in lung cancer screening trials like NCT00205413?
What adverse events are reported in low-dose CT screening for lung cancer and how are they managed in clinical practice?
How does the University of Wisconsin's observational CT/PET protocol compare to other lung cancer surveillance strategies in high-risk populations?
Trial Locations
- Locations (1)
University of Wisconsin Hospital and Clinics
🇺🇸Madison, Wisconsin, United States
University of Wisconsin Hospital and Clinics🇺🇸Madison, Wisconsin, United States